REQUEST A DEMO
Total
USD $0.00
Search more companies

Agp Limited (Pakistan)

Main Activities: Medicinal and Botanical Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Agp Limited Profile Updated: November 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is engaged as an independent pharmaceutical manufacturing company in Karachi, Pakistan.
It has steadily grown through manufacturing and marketing products under licensing arrangements with many companies of international repute and also through manufacturing and marketing its own brands. Today, it is one of the largest pharmaceutical companies in Pakistan, providing a broad range of pharmaceutical services.
The determination to upgrade the pharmaceutical resources of Pakistan and improvement of the quality of life of a common man was the key motivating factors in the inception of the company.
Vision:
AGP vision is based on quality and professionalism. Our people and resources are dedicated to provide quality products and ethical services to meet the needs of customers in a responsible manner.
There is an emphasis on employee pride, meticulous quality control and optimum resource utilization to achieve and maintain a leadership position in the healthcare industry, to grow through aggressive but ethical marketing, and to maintain synergy in our business. We are also conscious of our social responsibility to improve the quality of life of our customers, our staff and the society we inhabit; and every step taken at AGP is geared towards a better, healthier life for all as we practice our slogan we value life.
Mission:
Create value for our customers employees and shareholders through effective use of available resources by manufacturing and marketing healthcare products is an ethical manner conforming to international quality standards whilst leveraging company's brands market standing and image.
History:
2014 : The Company comprises of two plants, which previously operated as two separate companies namely AGP (Private) Limited (AGPPL) and AGP HealthCare (Private) Limited (AGPHC). These companies were acquired by a consortium led by OBS Pakistan (Private) Limited through an SPV namely Appollo Pharma Limited (APL) in July 2014.
2015: AGP Limited (Formerly Appollo Pharma Limited) was created subsequent to merger/ amalgamation of AGPPL and AGPHC with and into APL in December 2015.
2015 : APL was subsequently renamed to AGP Limited.
2018 : The Company was listed in Pakistan Stock Exchange on March 5, 2018.

Legal Address
B-23/C, S.I.T.E
Karachi; Sindh; Postal Code: 75700

Contact Details: Purchase the Agp Limited report to view the information.

Website: http://www.agp.com.pk

Basic Information
Total Employees:
Purchase the Agp Limited report to view the information.
Outstanding Shares:
Purchase the Agp Limited report to view the information.
Financial Auditors:
Purchase the Agp Limited report to view the information.
Incorporation Date:
1989
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
74.13%
Purchase this report to view the information.
3.14%
Purchase this report to view the information.
2.62%
Purchase this report to view the information.
2.47%
Purchase this report to view the information.
1.16%
Subsidiaries
Obs Agp (Private) Limited.
65%
Company Performance
Financial values in the chart are available after Agp Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PKR. Absolute financial data is included in the purchased report.
Net sales revenue
43.94%
Total operating revenue
44.86%
Operating profit (EBIT)
71.95%
EBITDA
65.37%
Net Profit (Loss) for the Period
17.2%
Total assets
4.07%
Total equity
7.86%
Operating Profit Margin (ROS)
3.91%
Net Profit Margin
-1.68%
Return on Equity (ROE)
0.54%
Debt to Equity Ratio
53.23%
Quick Ratio
0.27%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?